Table IV
Open in new tab

The scenario analysis results in the MS model at 1 year.

RegimenGnRHa plus ChemoChemoIncremental
In the USA
 Cost at 1 year ($)9740.744213.655527.09
 QALYs at 1 year0.890.870.02
 ICERs ($/QALY)276 354.65
RegimenGnRHa plus ChemoChemoIncremental
In the USA
 Cost at 1 year ($)9740.744213.655527.09
 QALYs at 1 year0.890.870.02
 ICERs ($/QALY)276 354.65

Chemo, chemotherapy; GnRHa, GnRH agonist; GnRHa plus Chemo, adding GnRHa during chemotherapy; MS, menopausal symptoms; ICER, incremental cost-effectiveness ratio; QALYs, quality-adjusted life-years.

Table IV
Open in new tab

The scenario analysis results in the MS model at 1 year.

RegimenGnRHa plus ChemoChemoIncremental
In the USA
 Cost at 1 year ($)9740.744213.655527.09
 QALYs at 1 year0.890.870.02
 ICERs ($/QALY)276 354.65
RegimenGnRHa plus ChemoChemoIncremental
In the USA
 Cost at 1 year ($)9740.744213.655527.09
 QALYs at 1 year0.890.870.02
 ICERs ($/QALY)276 354.65

Chemo, chemotherapy; GnRHa, GnRH agonist; GnRHa plus Chemo, adding GnRHa during chemotherapy; MS, menopausal symptoms; ICER, incremental cost-effectiveness ratio; QALYs, quality-adjusted life-years.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close